Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run

Charlotte-based Tikvah Management trimmed its CompoSecure (NYSE:CMPO) stake by 280,000 shares in Q3 (SEC filing dated Nov. 14), reducing its holding to 1.97 million shares valued at $41.01 million — ~12.11% of Tikvah’s $338.71 million reportable U.S. equity assets and an estimated $9.31 million reduction in position value. CompoSecure fundamentals remain positive: Q3 net sales +13% YoY to $120.9M, gross margin expanded to 59%, pro forma adjusted EBITDA +30% to $47.7M, management raised FY2025 guidance and issued 2026 targets; the company trades at $19.37 (up ~47% Y/Y) with a market cap of $2.45B and TTM revenue of $160.68M. The firm’s trim is presented as prudent risk management after a strong rally and ahead of a transformational business combination with Husky Technologies (~$7.4B combined valuation), which introduces leverage and integration risk that may complicate modeling and investor positioning.

Analysis

Market structure: Tikvah’s trim is capital-recycling from a single-stock concentration rather than a fundamental sell signal; price action will likely see short-term liquidity-driven pressure (5–15% range) but long-term demand for high-security payment cards and cold-storage wallets remains intact given CMPO’s 59% gross margins and +13% revenue growth. Direct beneficiaries are niche high-margin card manufacturers and crypto-custody tech (Arculus), while commodity card producers face margin squeeze as customers pay for security/IP. Cross-asset: increased idiosyncratic volatility in CMPO should raise options IV and produce modest flows out of small-cap fintech into large-cap tech (supporting GOOGL/AMZN), with negligible direct bond/FX impact absent debt financing surprises.

Risk assessment: Tail risks include adverse crypto custody regulation, a failed Husky combination integration, or leverage pushing net debt/EBITDA >3x which could force equity dilution — each could cut equity value 30–60% in downside scenarios. Immediate (days) risk is a trimming-driven pullback; short-term (weeks–months) hinge on Q4 guidance and M&A financing disclosures; long-term (12–36 months) depends on combined entity synergies and execution of cross-selling into enterprise clients. Hidden dependencies: recurring revenue from government/issuer contracts and supply-chain capacity for proprietary materials; loss or delay here is non-linear to EBITDA.

Trade implications: Direct play — asymmetric long exposure to CMPO sized 1–3% of portfolio with disciplined stops and add-on rules: buy at market, add if < $16 (≈-18%) and trim into strength. Volatility play — purchase 12-month LEAP calls (Jan 2027 $20 strike) sized to 0.5–1% notional for convex upside while selling 3–6 month covered calls if holding stock to finance carry. Hedged pair — go long CMPO (1.5% NAV) and short SPY (0.5% NAV) to express idiosyncratic re-rate while limiting beta.

Contrarian angles: The market is under-pricing the probability that the Husky tie-up drives enterprise SaaS/custody cross-sell; trimming by large holders is risk-management, not a conviction vote — a disciplined buyer can accumulate on dips to <$16 where implied upside exceeds 60% to a $28–30 fair-value in 12–18 months if integration is at least 50% accretive. Historical parallels (small-cap payments makers acquired and re-rated once scale synergies realized) suggest patience; however, if debt-funded at >3x leverage, downside may be persistent and warrants strict position caps.

Key Decisions for Investors

• Establish a 1.5% NAV long position in CMPO at market ($19.37) and add up to a total 3% NAV only if price falls below $16 (≈-18%); set a hard stop at 20% below average cost and target price $28–30 within 12–18 months (≈45–55% upside if integration executes).
• Buy Jan 2027 CMPO $20 LEAP calls equal to 0.5% NAV as asymmetric upside exposure; if initiated, sell 3–6 month covered calls (10–15% OTM) against stock holdings to fund theta if IV compresses after earnings or M&A clarity.
• Implement a hedged pair: long CMPO 1.5% NAV and short SPY 0.5% NAV to neutralize ~30–40% market beta while keeping idiosyncratic upside; close hedge if SPY moves >5% intra-month or CMPO confirms a break above $24 on 30-day volume expansion.
• Cap any single small-cap fintech/security position at 3% NAV and monitor covenant/leverage disclosures for the Husky deal: reduce exposure by 50% if pro forma net debt/adjusted EBITDA >3x on deal filing or if management delays integration milestones by >90 days.
• Within 60 days, monitor (1) Q4 guidance vs. current consensus, (2) financing terms of the Husky combination (debt/equity split and interest cost), and (3) any federal/state crypto custody regulatory notices; trigger rebalancing if guidance misses by >10% or financing increases leverage above 3x.